Drug Discovery Solutions

  1. Protein Degraders: From Discovery To Development 11/18/2025

    Leverage integrated platforms for targeted protein degradation and molecular glue solutions, from ligand identification to IND-enabling studies. Advanced screening and structural biology support accelerate discovery.

  2. Cell Line Development 2/17/2022

    Our experience developing mammalian and microbial cell lines and our analytical capabilities enable us to identify and select clones that meet your product’s specific parameters and characteristics.

  3. Research And Development Services For Gene Therapies 9/16/2025

    Our mission is clear: to help sponsors reduce costs, shorten timelines, and de-risk development, so they can achieve critical milestones, secure investments, and advance life-changing therapies.

  4. ADCs: From Design To Development 1/4/2024

    Explore how a CDMO with specialized teams can support running different stages in parallel to facilitate data sharing and clear communication, ultimately taking your ADC from design to development.

  5. Robust Cell Line Development With Leap-In Transposase® 5/15/2023

    Improve your cell line development and achieve high productivity, rapid timelines, low risk development, and robust genetic stability with an innovative platform.

  6. Expediting Drug Discovery From Concept To Commercialization 8/13/2024

    Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.

  7. Potency Assay Development — Creating Potential Together

    It is necessary to achieve a well-designed and developed potency assay as it is the only analytical technique that can demonstrate the biological mechanism of action and the link to clinical efficacy.

  8. Early Phase Bioassays And Analytics 6/26/2024

    The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.

  9. The Essential Role Of High-Quality Anti-Host Cell Protein (HCP) Antibody Reagents 9/13/2025

    Advance biopharmaceutical development with robust HCP detection strategies and high-quality antibody reagents to ensure product purity, safety, and regulatory compliance.

  10. DNA2.0 - Gene Optimization And Synthesis 2/13/2024

    ATUM is building on DNA2.0's reputation for rapid, reliable and accurate DNA synthesis. Using our proprietary GeneGPS® and VectorGPS® platforms we design constructs optimized to express in your system, whether that's a single gene in E. coli, a metabolic pathway in yeast or a complex bispecific antibody in mammalian cells.